Search bioRxiv⌕ Search

Biology subjects

Nilsson-Payant, B. E.

Publications and source records attributed to Nilsson-Payant, B. E..

8 recordsLinked to original sources

An ONT sequencing framework for hantavirus genome assembly, variant analysis, and defective viral genome characterization from whole-segment amplicons

Orthohantaviruses are zoonotic, tri-segmented negative-sense RNA viruses of rodents and other small mammals that can cause severe human disease. Whole genome sequencing remains difficult because of low viral loads, high sequence diversity, and an inherent instability of the viral L segment. Current tiled amplicon and hybrid-capture approaches do not capture the heterogeneity of virus populations, including defective viral genomes (DVGs), which have never been described for hantaviruses. Here, we present an Oxford Nanopore Technologies sequencing framework based on universal reverse transcription primers targeting the conserved genome termini of orthohantaviruses and a single species-specific primer pair per segment, enabling amplification and sequencing of complete S, M, and L segments. We also developed an accompanying bioinformatic pipeline that performs reference-guided assembly of hantavirus genomes, consensus generation, variant calling, and DVG classification using the newly developed ORCHID classification pipeline. We applied this approach to diverse Puumala virus strains from infected cell cultures and bank voles, to representative Old World and New World orthohantaviruses, and to highly pathogenic New World viruses in vivo. In all cases we were able to accurately reconstruct full hantavirus genomes. Notably, we found that hantavirus populations contain highly abundant DVGs and conserved L segment deletions, whereas the S and M segments remained largely intact. Together, this work provides a low-cost, broadly applicable and easily customisable workflow for hantavirus genomics and reveals DVGs as a previously unrecognized feature of hantavirus populations.

microbiology↗

Small aberrant viral genomes induce the innate immune response to arenaviruses

Arenaviruses are a family of negative-sense RNA viruses mainly found in rodents in which they cause chronic asymptomatic infections. Some arenaviruses, however, can occasionally infect humans and cause pathogenic viral haemorrhagic fevers. These viral haemorrhagic fevers are associated with a massively dysregulated immune response characterized by excessive release of pro-inflammatory cytokines resulting in hyperinflammatory immunopathology. Here, we systematically characterize the immune response of human cells to a wide panel of mammalian arenaviruses and identify a clear distinction between New World viruses, which uniformly induce a robust interferon response, and Old World viruses, which do not induce any significant host response. This innate immune response is primarily driven by RIG-I-mediated RNA sensing and might be aided by differences in viral interferon antagonist expression patterns. Furthermore, we identified differences in quantity and type of non-standard viral genomes produced in unpassaged Old World and New World virus infections. Finally, we demonstrate that small non-standard viral RNA expression by New World viruses are key drivers of the innate immune response and might help explain how the host response can shape viral disease phenotypes and inform triage of patients.

microbiology↗

Hantavirus stability and inactivation

Hantaviruses are zoonotic viruses that can cause highly pathogenic disease, including hantavirus cardiopulmonary syndrome (HCPS) and haemorrhagic fever with renal syndrome (HFRS), in humans with case-fatality rates of up to 50%. However, our understanding of the basic viral life cycle and the underlying causes of viral pathogenesis remains sparse, in large part due to a lack of molecular biology tools for hantaviruses and the need to work in high-containment laboratory facilities with these viruses. Here, we investigated the kinetics of infectious Tula virus (TULV) particle production in Vero E6 cells and subsequent stability in cell culture media. In addition, we evaluated the stability of infectious virus particles in response to different physical and environmental stresses, including heat, freezing, dehydration and UV exposure, answering key questions about the environmental transmission potential of hantaviruses. Interestingly, we observed a remarkable stability of TULV when stored at room temperature or colder, as well as after dehydration, which suggests that hantaviruses could remain infectious for a sustained period of time after being secreted by their host species. Subsequently, we determined the ability of commonly used virus inactivation methods, including RNA and protein extraction buffers, to inactivate TULV both in a cell-free and cell-associated context and found that TULV was efficiently inactivated by all these methods similar to other enveloped RNA viruses. Finally, we successfully validated the complete inactivation using these inactivation methods using the highly pathogenic HCPS-causing New World Andes virus (ANDV) and the HFRS-causing Old World Hantaan virus (HTNV). These results provide valuable information about safe and effective inactivation methods of viral samples and about the environmental risk potential of hantaviruses. Author summaryHantaviruses are ubiquitous rodent viruses and contain some of the most lethal known zoonotic viruses, including Andes virus (ANDV) and Hantaan virus (HTNV), with no FDA-or EMA-approved antiviral treatment or prevention options available. However, studying the molecular biology and pathogenesis of these viruses is significantly impeded by the need for biosafety level (BSL) 3 (or higher) containment facilities for most hantaviruses and a general lack of molecular biology tools. Our study provides a comprehensive analysis of the stability of infectious hantavirus particles in response to different physical and chemical stresses. We demonstrate that a diverse range of hantaviruses are effectively and quickly inactivated by commonly used generic viral inactivation methods. However, we also provide evidence for an inherent stability under environmental conditions that could enable prolonged transmission potential of hantaviruses, even after secretion from their host species. These data are essential information to design safe inactivation methods of infectious hantavirus material and offers insights into the environmental risks of hantavirus infections with implications for laboratory safety and public health measures.

microbiology↗

SARS-CoV-2 hijacks p38β/MAPK11 to promote viral protein translation

SARS-CoV-2, the causative agent of the COVID-19 pandemic, drastically modifies infected cells in an effort to optimize virus replication. Included is the activation of the host p38 mitogen-activated protein kinase (MAPK) pathway, which plays a major role in inflammation and is a central driver of COVID-19 clinical presentations. Inhibition of p38/MAPK activity in SARS-CoV-2-infected cells reduces both cytokine production and viral replication. Here, we combined genetic screening with quantitative phosphoproteomics to better understand interactions between the p38/MAPK pathway and SARS-CoV-2. We found that several components of the p38/MAPK pathway impacted SARS-CoV-2 replication and that p38{beta} is a critical host factor for virus replication, and it prevents activation of the type-I interferon pathway. Quantitative phosphoproteomics uncovered several SARS-CoV-2 nucleocapsid phosphorylation sites near the N-terminus that were sensitive to p38 inhibition. Similar to p38{beta} depletion, mutation of these nucleocapsid residues was associated with reduced virus replication and increased activation of type-I interferon signaling. Taken together, this study reveals a unique proviral function for p38{beta} that is not shared with p38 and supports exploring p38{beta} inhibitor development as a strategy towards developing a new class of COVID-19 therapies. ImportanceSARS-CoV-2 is the causative agent of the COVID-19 pandemic that has claimed millions of lives since its emergence in 2019. SARS-CoV-2 infection of human cells requires the activity of several cellular pathways for successful replication. One such pathway, the p38 mitogen-activated protein kinase (MAPK) pathway, is required for virus replication and disease pathogenesis. Here, we applied systems biology approaches to understand how MAPK pathways benefit SARS-CoV-2 replication to inform the development of novel COVID-19 drug therapies.

microbiology↗

The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis

Influenza A viruses are negative-sense RNA viruses that rely on their own viral replication machinery to replicate and transcribe their segmented single-stranded RNA genome. The viral ribonucleoprotein complexes in which viral RNA is replicated consist of a nucleoprotein scaffold around which the RNA genome is bound, and a heterotrimeric RNA-dependent RNA polymerase that catalyzes viral replication. The RNA polymerase copies the viral RNA (vRNA) via a replicative intermediate, called the complementary RNA (cRNA), and subsequently uses this cRNA to make more vRNA copies. To ensure that new cRNA and vRNA molecules are associated with ribonucleoproteins in which they can be amplified, the active RNA polymerase recruits a second polymerase to encapsidate the cRNA or vRNA. Host factor ANP32A has been shown to be essential for viral replication and to facilitate the formation of a dimer between viral RNA polymerases and differences between mammalian and avian ANP32A proteins are sufficient to restrict viral replication. It has been proposed that ANP32A is only required for the synthesis of vRNA molecules from a cRNA, but not vice versa. However, this view does not match recent molecular evidence. Here we use minigenome assays, virus infections, and viral promoter mutations to demonstrate that ANP32A is essential for both vRNA and cRNA synthesis. Moreover, we show that ANP32 is not only needed for the actively replicating polymerase, but also for the polymerase that is encapsidating nascent viral RNA products. Overall, these results provide new insights into influenza A virus replication and host adaptation. IMPORTANCEZoonotic avian influenza A viruses pose a constant threat to global health and they have the potential to cause highly pathogenic pandemic outbreaks. Species variations in host factor ANP32A play a key role in supporting the activity of avian influenza A virus RNA polymerases in mammalian hosts. Here we show that ANP32A acts at two stages in the influenza A virus replication cycle, supporting recent structural experiments and in line with its essential role. Understanding how ANP32A supports viral RNA polymerase activity and how it supports avian polymerase function in mammalian hosts is important for understanding influenza A virus replication and the development of antiviral strategies against influenza A viruses.

microbiology↗

Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus

Infections with respiratory viruses can spread via liquid droplets and aerosols, and cause diseases such as influenza and COVID-19. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of respiratory droplets containing these viruses. However, influenza A viruses and coronaviruses are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as absorption of viruses make measuring and optimizing the inactivation characteristics difficult. Here we used polyamide 6.6 (PA66) fibers that had zinc ions embedded during the polymerisation process and systematically investigated if these fibers can absorb and inactivate pandemic SARS-CoV-2 and influenza A virus H1N1. We find that these viruses are readily absorbed by PA66 fabrics and inactivated by zinc ions embedded into this fabric. The inactivation rate (pfu{middle dot}gram-1{middle dot}min-1) exceeds the number of active virus particles expelled by a cough and supports a wide range of viral loads. Moreover, we found that the zinc content and the virus inactivating property of the fabric remain stable over 50 standardized washes. Overall, these results provide new insight into the development of "pathogen-free" PPE and better protection against RNA virus spread.

microbiology↗

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids

Summary ParagraphThe SARS-CoV-2 virus has caused already over 3.5 million COVID-19 cases and 250,000 deaths globally. There is an urgent need to create novel models to study SARS-CoV-2 using human disease-relevant cells to understand key features of virus biology and facilitate drug screening. As primary SARS-CoV-2 infection is respiratory-based, we developed a lung organoid model using human pluripotent stem cells (hPSCs) that could be adapted for drug screens. The lung organoids, particularly aveolar type II cells, express ACE2 and are permissive to SARS-CoV-2 infection. Transcriptomic analysis following SARS-CoV-2 infection revealed a robust induction of chemokines and cytokines with little type I/III interferon signaling, similar to that observed amongst human COVID-19 pulmonary infections. We performed a high throughput screen using hPSC-derived lung organoids and identified FDA-approved drug candidates, including imatinib and mycophenolic acid, as inhibitors of SARS-CoV-2 entry. Pre- or post-treatment with these drugs at physiologically relevant levels decreased SARS-CoV-2 infection of hPSC-derived lung organoids. Together, these data demonstrate that hPSC-derived lung cells infected by SARS-CoV-2 can model human COVID-19 disease and provide a valuable resource to screen for FDA-approved drugs that might be repurposed and should be considered for COVID-19 clinical trials.

microbiology↗

An inability to maintain the ribonucleoprotein genomic structure is responsible for host detection of negative-sense RNA viruses

Cellular biology has a uniformity not shared amongst viruses. This is perhaps best exemplified by negative-sense RNA viruses that encode their genetic material as a ribonucleoprotein complex composed of genome, RNA-dependent RNA polymerase, and the nucleoprotein. Here we demonstrate that limiting nucleoprotein availability not only universally culminates in a replicative catastrophe for negative-sense RNA viruses, but it results in the production of aberrant genomic material and induction of the interferon-based host defenses. This dynamic illustrates the tremendous stress imposed on negative-sense RNA viruses during replication as genomic products accumulate in an environment that requires an increasing demand on nucleoprotein availability. We show that limiting NP by RNA interference or drug targeting blocks replication and primes neighboring cells through the production of interferon. Together, these results demonstrate that the nucleoprotein represents the Achilles heel of the entire phylum of negative-sense RNA viruses. Here we establish this principle for a diverse collection of human pathogens and propose that the nucleoprotein should be a primary target for the development of future antiviral drugs. HIGHLIGHTSO_LILimited levels of NP result in production of defective viral genomes C_LIO_LIDefective viral genomes and viral antagonists are key determinants of the host antiviral response C_LIO_LIThe host response and defective viral genome generation further exasperate NP availability C_LIO_LINP is an optimal drug target for the whole phylum of negative-sense RNA viruses C_LI

microbiology↗